[{"name":"Conclusions (ID 751)","mode":"","is_cme":false,"info":{"presentation":"Conclusions <small>(ID 751)<\/small>","session":"Seattle Genetics - Industry Satellite Symposium: Improving outcomes after T-DM1 - a new horizon for HER2+ mBC patients <small>(ID 75)<\/small>","presenter":"Alicia Okines<small> (London, United Kingdom)<\/small>","photo":null},"playlist":[{"name":"Conclusions","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/breast2020\/75\/v\/751_2c.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/breast2020\/75\/v\/751_2c.mp4","cover":"","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/breast2020\/75\/v\/751_2c.vtt","thumbnails":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/breast2020\/75\/v\/751_2c-thumbnails.vtt"}]}]{"provider":"CTI","provider_live":0,"type":1,"code":"7L240dX02Vk"}